| COVID-19 and the kidney: from epidemiology to clinical practice I Gagliardi, G Patella, A Michael, R Serra, M Provenzano, M Andreucci Journal of clinical medicine 9 (8), 2506, 2020 | 159 | 2020 |
| Dietary salt restriction in chronic kidney disease: a meta-analysis of randomized clinical trials C Garofalo, S Borrelli, M Provenzano, T De Stefano, C Vita, P Chiodini, ... Nutrients 10 (6), 732, 2018 | 150 | 2018 |
| Sodium intake and chronic kidney disease S Borrelli, M Provenzano, I Gagliardi, A Michael, ME Liberti, L De Nicola, ... International journal of molecular sciences 21 (13), 4744, 2020 | 105 | 2020 |
| Incremental dialysis in ESRD: systematic review and meta-analysis C Garofalo, S Borrelli, T De Stefano, M Provenzano, M Andreucci, ... Journal of Nephrology 32, 823-836, 2019 | 100 | 2019 |
| Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer M Provenzano, G Coppolino, T Faga, C Garofalo, R Serra, M Andreucci Reviews in cardiovascular medicine 20 (4), 209-220, 2019 | 97 | 2019 |
| Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies R Minutolo, FB Gabbai, M Provenzano, P Chiodini, S Borrelli, C Garofalo, ... Nephrology Dialysis Transplantation 33 (11), 1942-1949, 2018 | 92 | 2018 |
| Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized crossover clinical trial M Provenzano, MJ Puchades, C Garofalo, N Jongs, L D’Marco, ... Journal of the American Society of Nephrology 33 (8), 1569-1580, 2022 | 78 | 2022 |
| SGLT2 inhibitors: nephroprotective efficacy and side effects C Garofalo, S Borrelli, ME Liberti, M Andreucci, G Conte, R Minutolo, ... Medicina 55 (6), 268, 2019 | 78 | 2019 |
| Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care L De Nicola, M Provenzano, P Chiodini, S Borrelli, C Garofalo, M Pacilio, ... PloS one 10 (5), e0127071, 2015 | 71 | 2015 |
| Unraveling cardiovascular risk in renal patients: a new take on old tale M Provenzano, G Coppolino, L De Nicola, R Serra, C Garofalo, ... Frontiers in Cell and Developmental Biology 7, 314, 2019 | 70 | 2019 |
| The association of matrix metalloproteinases with chronic kidney disease and peripheral vascular disease: a light at the end of the tunnel? M Provenzano, M Andreucci, C Garofalo, T Faga, A Michael, N Ielapi, ... Biomolecules 10 (1), 154, 2020 | 68 | 2020 |
| An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency … M Simeoni, ML Citraro, A Cerantonio, F Deodato, M Provenzano, ... European journal of nutrition 58, 2145-2156, 2019 | 59 | 2019 |
| Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients F Mallamaci, G Tripepi, G D’Arrigo, S Borrelli, C Garofalo, G Stanzione, ... Clinical Journal of the American Society of Nephrology 14 (2), 233-240, 2019 | 58 | 2019 |
| Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective … M Provenzano, P Chiodini, R Minutolo, C Zoccali, V Bellizzi, G Conte, ... Nephrology Dialysis Transplantation 35 (1), 138-147, 2020 | 51 | 2020 |
| Sex differences in the progression of CKD among older patients: pooled analysis of 4 cohort studies R Minutolo, FB Gabbai, P Chiodini, M Provenzano, S Borrelli, C Garofalo, ... American Journal of Kidney Diseases 75 (1), 30-38, 2020 | 47 | 2020 |
| The kidney protective effects of the sodium–glucose cotransporter-2 inhibitor, dapagliflozin, are present in patients with CKD treated with mineralocorticoid receptor antagonists M Provenzano, N Jongs, P Vart, BV Stefánsson, GM Chertow, ... Kidney International Reports 7 (3), 436-443, 2022 | 43 | 2022 |
| Up-date on diabetic nephropathy MC Pelle, M Provenzano, M Busutti, CV Porcu, I Zaffina, L Stanga, F Arturi Life 12 (8), 1202, 2022 | 42 | 2022 |
| Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ... Nature medicine 29 (10), 2438-2457, 2023 | 39 | 2023 |
| The role of prognostic and predictive biomarkers for assessing cardiovascular risk in chronic kidney disease patients M Provenzano, M Andreucci, L De Nicola, C Garofalo, Y Battaglia, ... BioMed research international 2020, 2020 | 38 | 2020 |
| Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis N Ielapi, N Licastro, M Provenzano, M Andreucci, S Franciscis, R Serra Biomarkers in medicine 14 (9), 713-716, 2020 | 38 | 2020 |
